Using decision aids to improve treatment choices for women with breast cancer

Abstract

Breast cancer is the most frequently diagnosed cancer in women worldwide and decision-making regarding treatment options can be complex; however, patients often desire to be involved in health-related decisions. There has been a growing body of research into decision-support tools such as decision aids (DAs). Generally, DAs outperform standard care over a range of decision-making outcomes and there are some that have been developed for use with breast cancer patients across the treatment trajectory, which have been evaluated for use in practice. There is scope for developing additional DAs for cancer patients, however, there are some limitations and barriers that need to be overcome as part of the implementation process. Consideration for the mechanisms for maintaining relevancy of materials and ease of accessibility is also needed.A diagnosis of cancer brings with it many complex decisions regarding treatment.Patients want to be actively involved in treatment decision-making.Decision aids (DAs) are effective tools in improving decision-making.Many patients have found DAs to be acceptable and helpful.DAs need to be evaluated for a particular setting before clinical use.Clinician support and acceptance of DAs is important for effective implementation.DAs with proven efficacy should be a part of standard care to help inform treatment choices.